| Abstrakt: |
A prospective study was carried out to evaluate safety, in-hospital clinical end points and early outcome in a consecutive series of 212 patients with coronary artery disease (CAD) who underwent coronary angioplasty in Manmohan Cardiothoracic Vascular and Transplant Centre from October 2012 to April 2014 over a period of 18 months. All patients who underwent angioplasty during the specified period were included in the study. Majority of the patients were male (84.4%). Hypertension was found in 31%, diabetes in 29%, dyslipidemia in 23% and smoking in 19%. A total of 253 stents were deployed. Patients with single vessel coronary artery disease (SVD) were 75%, double vessel coronary artery disease (DVD) 23% and triple vessel coronary artery disease (TVD) was only 1.8%. Indications for stent implantation were stable CAD in 110 (51.8%), unstable angina (UA) in 19 (8.9%), Non ST segment elevation Myocardial Infarction (NSTEMI) in 31 (14.6%) and ST segment elevation Myocardial Infarction (STEMI) in 52 (24.5%). Eighty one percent received drug eluting stent (DES); while 19% received bare metal stent (BMS). Over all procedural success was obtained in 206 (97.6%) cases. Mortality occurred in 4 cases (1.9%) during index hospitalization. All these patients were in cardiogenic shock due to acute STEMI. On follow up, one case of sub acute stent thrombosis (0.4%) and 3 cases (6.3%) of instent restenosis were observed among 47 BMS cases. Coronary Angioplasty was found to be a safe and effective method of coronary revascularization with low in-hospital morbidity and mortality even in high risk elective and emergency procedures. |
